Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FURIN | P09958 | 10/20 | 0.42 |
| ▸ | NMT2 | O60551 | 1/20 | 0.37 |
| ▸ | NMT1 | P30419 | 1/20 | 0.37 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.37 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.37 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.36 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.36 |
| ▸ | CTSL | P07711 | 1/20 | 0.35 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.35 |
| ▸ | C3AR1 | Q16581 | 1/20 | 0.35 |
| ▸ | QRFPR | Q96P65 | 1/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.34 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29385639 | 0.88 | C3AR1 (0.45) | FURINC3AR1 | |
| SCHEMBL8355213 | 0.88 | NMT2 (0.45) | FURINNMT2NMT1SIRT6SIRT1 | |
| SCHEMBL21437110 | 0.88 | NMT2 (0.45) | FURINNMT2NMT1SIRT6SIRT1 | |
| SCHEMBL22698746 | 0.87 | FURIN (0.38) | FURINNMT2NMT1SIRT6SIRT1 | |
| SCHEMBL24191073 | 0.84 | C3AR1 (0.42) | FURINPRSS1C3AR1QRFPR | |
| SCHEMBL31319761 | 0.83 | C3AR1 (0.41) | FURINPRSS1C3AR1QRFPR | |
| SCHEMBL29590144 | 0.82 | GLO1 (0.39) | FURINNMT2NMT1SIRT6SIRT1 | |
| SCHEMBL30087255 | 0.81 | FURIN (0.43) | FURINNMT2NMT1PRSS1QRFPR | |
| SCHEMBL29379162 | 0.81 | C3AR1 (0.42) | FURINNMT2NMT1CTSLC3AR1 | |
| SCHEMBL7205976 | 0.80 | FURIN (0.45) | FURINNMT2NMT1SIRT6SIRT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025031383-A1 | BIFUNCTIONAL LINKER COMPOUND, ANTIBODY DRUG CONJUGATE, PREPARATION METHOD FOR ANTIBODY DRUG CONJUGATE, AND USE OF ANTIBODY DRUG CONJUGATE | 杭州爱科瑞思生物医药有限公司 | 2025-02-13 | — | — | WO | claimed |
| WO-2025031383-A1 | BIFUNCTIONAL LINKER COMPOUND, ANTIBODY DRUG CONJUGATE, PREPARATION METHOD FOR ANTIBODY DRUG CONJUGATE, AND USE OF ANTIBODY DRUG CONJUGATE | 杭州爱科瑞思生物医药有限公司 | 2025-02-13 | — | — | WO | disclosed |